Cedryl Acetate

Cedryl Acetate

SCHEMBL8515562

CC(=O)OC1(C)CCC23CC1C(C)(C)C2CCC3C

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 2/20 1.00
▸ CYP17A1 P05093 3/20 0.59
▸ CYP19A1 P11511 3/20 0.59
▸ ALDH1A1 P00352 1/20 0.58
▸ LMNA P02545 1/20 0.58
▸ THRB P10828 1/20 0.58
▸ MAPK1 P28482 1/20 0.58
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cedryl Acetate SCHEMBL17409526 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL18138231 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL27084023 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL17627733 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL18604009 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL1532502 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL30392817 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL8737981 1.00 ALOX15 (1.00) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
SCHEMBL8736276 0.86 ALOX15 (0.75) ALOX15CYP17A1CYP19A1ALDH1A1LMNA
Cedryl Acetate SCHEMBL22498452 0.85 ALOX15 (0.72) ALOX15CYP17A1CYP19A1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 186 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 — — US claimed
EP-4446001-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2024-10-16 — — EP claimed
US-11944727-B2 Air freshening device GIVAUDAN SA (CH) 2024-04-02 — — US claimed
US-20230212483-A1 Improvements in or Relating to Organic Compounds GIVAUDAN SA (CH) 2023-07-06 — — US claimed
EP-4188589-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS Givaudan SA (CH) 2023-06-07 — — EP claimed
US-20230151305-A1 FRAGRANCE COMPOSITION SA, GIVAUDAN (CH) 2023-05-18 — — US claimed
CN-113265305-B Detergent and preparation method thereof 广东振健生物科技股份有限公司 2023-05-02 — — CN claimed
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT FIRMENICH SA (CH) 2023-03-23 — — US claimed
EP-4084769-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT Firmenich SA (CH) 2022-11-09 — — EP claimed
CN-113278474-B Detergent and towel washing process 杭州诺诚洗涤科技有限公司 2022-05-17 — — CN claimed
WO-2016049455-A1 PERSONAL CARE COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 — — WO claimed
WO-2016049407-A1 ABSORBENT ARTICLE COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 — — WO claimed
WO-2016049404-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 — — WO claimed
WO-2016049394-A1 CLEANING AND/OR TREATMENT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 — — WO claimed
US-20160090557-A1 SUBSTRATES COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
WO-2016049395-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY (US) 2016-03-31 — — WO claimed
US-20160090556-A1 PRODUCTS COMPRISING MALODOR REDUCTION MATERIALS THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2016-03-31 — — US claimed
US-9233353-B2 Carrier system for fragrances BASF SE (DE) 2016-01-12 — — US claimed
EP-1869150-B1 PERFUME COMPOSITIONS GIVAUDAN NEDERLAND SERVICES BV (NL) 2012-05-30 — — EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 ALOX15 40/4885CYP17A1 184/4885CYP19A1 248/4885
US-20230093639-A1 PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT PORCN, FAAH2, FASN ALOX15 115/4885CYP17A1 1580/4885CYP19A1 838/4885
US-20160089317-A1 ANTIPERSPIRANT AND DEODORANT COMPOSITIONS COMPRISING MALODOR REDUCTION COMPOSITIONS LPO, QDPR, TYR ALOX15 180/4885CYP17A1 1162/4885CYP19A1 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback